Understanding Advanced Cancer Through Tissue Donation
Rapid Autopsy
This program helps researchers learn more about advanced cancer and how it resists treatments by studying tissue samples donated by patients after they pass away.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11086195 on NIH RePORTER |
What this research studies
This program focuses on understanding advanced cancer by performing rapid autopsies shortly after a patient's death. By carefully examining these tissue samples, researchers can learn about changes in cancer cells and their surroundings that lead to disease progression and resistance to treatments like immunotherapy. The program also ensures high-quality tissue collection and storage, building a valuable resource for future discoveries. This work helps scientists develop better, more personalized treatments for cancer patients.
Who could benefit from this research
Good fit: Patients with advanced cancer who wish to contribute to scientific understanding after their passing are ideal candidates for this program.
Not a fit: Patients who are not diagnosed with advanced cancer or who do not wish to donate tissue after death would not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of advanced cancer, helping to develop new and more effective treatments, especially for drug resistance.
How similar studies have performed: This program is a well-established shared resource that has been highly successful in supporting cancer research by providing crucial postmortem tissue samples.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Hooper, Jody Elizabeth — Johns Hopkins University
- Study coordinator: Hooper, Jody Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.